Esperion Therapeutics | ESPR - Market Capitalization

Stock Price
2.78
Daily Change
0.16 5.92%
Monthly
-17.41%
Yearly
70.25%
Q1 Forecast
2.47

Esperion Therapeutics reported $520M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Alterity Therapeutics Limited AUD 11M 5M Jun/2023
Amarin USD 308M 18M Mar/2026
Amgen USD 176.25B 24.32B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Cipla INR 1.22T 6.47B Dec/2025
CSL USD 71.32B 15.44B Mar/2026
Cytokinetics USD 7.77B 1.19B Dec/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Esperion Therapeutics USD 475M 410M Mar/2026
Geron USD 843M 31M Dec/2025
Grifols EUR 2.02B 4.34B Mar/2026
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 133M 105M Mar/2026
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Pfizer USD 153.96B 12.4B Mar/2026
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024